TrialCancer gene therapy2012

Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer.

N Hanna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.